PROS1 and Alzheimer disease: Network analysis of AD at each stage of disease progression demonstrated dysregulation in actin-based cytoskeletal and cell–cell junction regulatory proteins in the initial stages, while the intermediate stages demonstrated impaired mitochondrial functions and redox signaling imbalance, and impaired pre-mRNA splicing and RNA stability in the advanced disease stages (Li et al., 2019).